Generation of a Vero-Based Packaging Cell Line to Produce SV40 Gene Delivery Vectors for Use in Clinical Gene Therapy Studies

Replication-defective (RD) recombinant simian virus 40 (SV40)-based gene delivery vectors hold a great potential for clinical applications because of their presumed non-immunogenicity and capacity to induce immune tolerance to the transgene products in humans. However, the clinical use of SV40 vecto...

Descripción completa

Detalles Bibliográficos
Autores principales: Toscano, Miguel G., van der Velden, Jeroen, van der Werf, Sybrand, Odijk, Machteld, Roque, Ana, Camacho-Garcia, Rafael J., Herrera-Gomez, Irene G., Mancini, Irene, de Haan, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537168/
https://www.ncbi.nlm.nih.gov/pubmed/28791314
http://dx.doi.org/10.1016/j.omtm.2017.06.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537168/
https://www.ncbi.nlm.nih.gov/pubmed/28791314
http://dx.doi.org/10.1016/j.omtm.2017.06.007

Ejemplares similares